Sleep Disorders, Intrinsic D020919

Diseases [C] » Nervous System Diseases [C10] » Sleep Wake Disorders » Dyssomnias » Sleep Disorders, Intrinsic

Psychiatry and Psychology [F] » Mental Disorders [F03] » Sleep Wake Disorders » Dyssomnias » Sleep Disorders, Intrinsic

Description

Dyssomnias (i.e., insomnias or hypersomnias) associated with dysfunction of internal sleep mechanisms or secondary to a sleep-related medical disorder (e.g., sleep apnea, post-traumatic sleep disorders, etc.). (From Thorpy, Sleep Disorders Medicine, 1994, p187)   MeSH

Subtype Terms (5)

Disorders of Excessive Somnolence
18 drugs (10 approved, 8 experimental)

Nocturnal Myoclonus Syndrome
 

Restless Legs Syndrome
42 drugs (32 approved, 10 experimental)

Sleep Apnea Syndromes
80 drugs (66 approved, 14 experimental)

Sleep Initiation and Maintenance Disorders
132 drugs (64 approved, 68 experimental)



Organization Involved with Phase 3 Indications (1)

Organization Involved with Phase 1 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.